SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors focus on its expansion from an NFT collection into a global retail brand, highlighted by successful toy sales and new product integrations. The community remains deeply divided, with many actively accumulating at current levels on the belief that long-term brand utility outweighs recent price volatility.

NEOS ETF Trust - NEOS S&P 500 High Income ETF

NEOS S&P 500 High Income ETF

SPYI is trending as investors favor its tax-efficient monthly income strategy and price resilience compared to more volatile covered-call alternatives. The community is actively debating its role in 

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

Vechain is currently a major point of contention among investors, with vocal critics pointing to stagnant price action and declining market cap, while others hold onto hopes for a long-term recovery tied to real-world infrastructure initiatives like Digital Product Passports. The community remains deeply polarized, with many users expressing extreme frustration over the coin's lack of momentum compared to the broader market, while a subset of bulls continues to accumulate in anticipation of potential utility-driven growth.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

Degen

DEGEN is trending as the community rallies around ongoing token burns, buybacks, and anticipation for upcoming ecosystem developments like the new social-utility app. Investors are actively debating the token's potential for a significant breakout, with many drawing parallels to past viral cycles while others raise concerns about volatility and the project's long-term sustainability.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending as investors react to positive Phase 2 data from its registrational trial for miv-cel in Stiff Person Syndrome, which showed significant, durable mobility improvements for patients. The clinical win has triggered intense discussion regarding the company's potential as a first-to-market leader in autoimmune CAR-T therapies and its heightened appeal as a potential M&A target.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending as investors react to the firm's record cash pile, a major leadership transition from Warren Buffett to Greg Abel, and a recent strategic $10 billion investment in Alphabet. The community is actively debating the implications of Berkshire's massive capital reserves, its shifting tech portfolio, and the company's ability to maintain its disciplined, long-term value strategy in a high-valuation market.

Volatility Shares Trust - 2x Bitcoin Strategy ETF

Volatility Shares 2x Bitcoin Strategy ETF

Investors are actively debating the recent volatility and performance of the 2x Bitcoin Strategy ETF as it struggles with price consolidation during market hours. The community is focused on whether this period represents a long-term accumulation opportunity or if ongoing liquidity concerns will continue to hinder the expected upside.

Volvo AB engages in the design, manufacture, and market of commercial vehicles. It operates through the following segments: Trucks, Construction Equipment, Buses, Volvo Penta, and Financial Services. The Trucks segment includes the production, development, and logistics for powertrain and parts. The Volvo Penta segment markets marine and industrial engines. The company was founded by Assar-Thorvald Nathanael-Gabrielsson and Erik Gustaf Larson in 1927 and is headquartered in Goteborg, Sweden.

Volvo AB - ADR - Unsponsored

VOLVO AB/ADR

Volvo is currently a focal point in the automotive sector as investors monitor its strategic expansion into autonomous freight corridors and major collaborations with companies like Aurora Innovation. The community is closely watching how the manufacturer balances its transition to electric vehicle production amidst ongoing supply chain constraints and shifting regulatory landscapes across North American and European markets.

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sutro Biopharma Inc

Sutro Biopharma is trending due to the unexpected decision to deprioritize its lead clinical asset, Luvelta, alongside a 50% workforce reduction and leadership transition. Community discussion is sharply divided, focusing on frustration over the sudden strategic shift to early-stage programs versus the potential value of remaining ADC technology and upcoming clinical data.

Amplify ETF Trust - Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF (SILJ) is actively being traded as investors weigh significant silver price volatility against a tightening physical supply and strong industrial demand. Community discourse is heavily focused on the disconnect between silver's recent price action and the performance of junior miners, with many market participants debating whether the sector represents a coiled spring for a massive catch-up rally or if broader market margin pressures will lead to further short-term consolidation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have...

Jim Cramer Recommends Elanco Over Zoetis

Jim Cramer Recommends Elanco Over Zoetis...

ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt PR Newswire NEW YORK, June 4, 2026 Time-Sensitive: Allegations Focus on Concealed FDA...

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS ANGELES, June 4, 2026 LOS ANGELES, June 4, 2026 /PRNewswire/ -- The Law Offices of Frank R...

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, both dates inclusive (the Class Period), have until July 27, 2026 to seek appointment as lead plaintiff of the Zoetis class action...

Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zoetis Inc. (Zoetis or the Company) (NYSE: ZTS) securities between January 14, 2025 and May...

ZTS DEADLINE: Levi & Korsinsky Reminds Zoetis Inc. Investors of Upcoming Securities Class Action Deadline

ZTS DEADLINE: Levi & Korsinsky Reminds Zoetis Inc. Investors of Upcoming Securities Class Action Deadline ZTS DEADLINE: Levi & Korsinsky Reminds Zoetis Inc. Investors of Upcoming Securities Class Action Deadline PR Newswire NEW YORK, June 3, 2026 Key Dates and Disclosure Events Shareholders Need to...

Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS

Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS PR Newswire LOS ANGELES, June 3, 2026 LOS ANGELES, June 3, 2026 /PRNewswire/ -- The DJS Law...

Deadline Approaching: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Zoetis Inc. (Zoetis or the Company) (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, inclusive (the Class...

Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?

Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Current Price	$79.44
Prev Close	$79.52
Open	$79.54
Dividend Yield	1.61%
50-Day Moving Average	$101.06
Beta	0.72
Avg. Volume	9.8M
PE Ratio	13.16

52-Week High	$169.50
52-Week Low	$72.38
Market Capitalization	$33.3B
EPS (Annual)	$6.02
Price to Book	10.33
Revenue Per Employee	$652,896.55

ZTSZoetis Inc - Ordinary Shares - Class A

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZTS News